Back to Search Start Over

Protocol for the validation of sensitivity and specificity of the Cow's Milk-related Symptom Score (CoMiSS) against open food challenge in a single-blinded, prospective, multicentre trial in infants

Authors :
Ralf G. Heine
Rajat Mukherjee
Mikael Kuitunen
Yvan Vandenplas
Christophe Dupont
Philippe Eigenmann
Zheng-Yan Zhao
Andrea von Berg
Carmen Ribes-Koninkx
Neil Shah
Hania Szajewska
Arne Høst
Clinicum
Children's Hospital
University of Helsinki
HUS Children and Adolescents
Clinical sciences
Growth and Development
Pediatrics
Faculty of Sciences and Bioengineering Sciences
Source :
on behalf the Chinese CoMiSS Investigator Team. 2018, ' Protocol for the validation of sensitivity and specificity of the Cow's Milk-related Symptom Score (CoMiSS) against open food challenge in a single-blinded, prospective, multicentre trial in infants ', BMJ Open, vol. 8, no. 5, e019968 . https://doi.org/10.1136/bmjopen-2017-019968, BMJ Open, r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe, instname, BMJ Open, Vol. 8, No 5 (2018) P. e019968
Publication Year :
2018

Abstract

INTRODUCTION: The symptoms of cow's milk protein allergy (CMPA) in infancy can be non-specific which may delay a correct diagnosis and cause adverse clinical outcomes. The diagnosis of non-IgE-mediated CMPA is particularly complex as it involves a 2 to 4 week elimination diet followed by oral food challenge (OFC). The Cow's Milk-related Symptom Score (CoMiSS) is a clinical resource for primary healthcare providers which aims to increase awareness of CMPA symptoms to facilitate an earlier diagnosis. The aim of the present study is to assess if the CoMiSS can be used as a potential diagnostic tool in infants with suspected CMPA.METHODS AND ANALYSIS: Exclusively formula-fed infants aged 0-6 months presenting with symptoms suggestive of CMPA will be included in this prospective, multicentre trial which will be conducted in 10 centres in China. All infants will commence a 2-week trial of an amino acid-based formula (AAF) while eliminating all cow milk protein from their diets. After the AAF treatment period, infants will undergo an open OFC in hospital with standard cow's milk formula, followed by an open home challenge for another 2 weeks. Clinical symptoms will be documented on standardised symptom scorecards. The CoMiSS will be determined at study entry (CoMiSS 1, before the start of the AAF), after 2 weeks (CoMiSS 2, before the OFC) and after a further period of 2 weeks or when symptoms suggestive of CMPA reappear (CoMiSS 3). Weight and length will be measured at each visit. The difference between CoMiSS 1 and 2 as a predictor of the OFC outcome will also be assessed. The diagnostic accuracy of the baseline CoMiSS will be calculated.ETHICS AND DISSEMINATION: The study was approved by the Hunan Children's Hospital Medical Ethics Committee, Hunan, China. The findings of this trial will be submitted for publication in a peer-reviewed journal in paediatric nutrition or gastroenterology. Abstracts will be submitted to the relevant national and international conferences.TRIAL REGISTRATION NUMBER: NCT03004729; Pre-results.

Details

Language :
English
ISSN :
20446055
Database :
OpenAIRE
Journal :
on behalf the Chinese CoMiSS Investigator Team. 2018, ' Protocol for the validation of sensitivity and specificity of the Cow's Milk-related Symptom Score (CoMiSS) against open food challenge in a single-blinded, prospective, multicentre trial in infants ', BMJ Open, vol. 8, no. 5, e019968 . https://doi.org/10.1136/bmjopen-2017-019968, BMJ Open, r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe, instname, BMJ Open, Vol. 8, No 5 (2018) P. e019968
Accession number :
edsair.doi.dedup.....dadbe163859eae0ec1c8fab210062d2b
Full Text :
https://doi.org/10.1136/bmjopen-2017-019968